FDA approves Telix brain cancer imaging drug Pixclara (TLX:NASDAQ)
· seekingalpha.com
FDA approves Telix Pharmaceuticals’ Pixclara (FET-PET) for glioma imaging, helping distinguish recurrence from treatment effects.
The Food and Drug Administration approved Telix Pharmaceuticals’ (TLX) Pixclara, a radioactive imaging drug used to help evaluate patients with glioma, the co...